Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Preventing Stroke in Patients With Atrial Fibrillation

Article Abstract:

Aspirin is probably adequate to prevent stroke in most patients with atrial fibrillation but warfarin may be needed for those at high risk of stroke. Atrial fibrillation occurs when the upper part of the heart beats so rapidly it can throw off blood clots that travel to the brain and cause a stroke. Researchers reviewed several clinical trials comparing warfarin and aspirin with placebo in patients with atrial fibrillation. Both drugs can prevent blood clots. Aspirin was sufficient in people under 65 who had no other risk factors for stroke. However, warfarin was more effective in older patients who had other risk factors.

Author: Ezekowitz, Michael D.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1999
Evaluation, Complications and side effects, Atrial fibrillation, Warfarin

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Rising stroke rates spur efforts to identify risks, prevent disease

Article Abstract:

Public education is needed to teach people the risks and warning signs of stroke. Stroke is caused by a blood clot that blocks the flow of blood to an area of the brain. The same condition in the heart is called a heart attack. Stroke is a medical emergency and can be treated with drugs that break up the clot. However, patients and their families must know the warning signs so they can reach the hospital quickly. The National Stroke Association has developed guidelines for the public, which will be urgently needed as baby boomers reach the age of greatest risk.

Author: Stephenson, Joan
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Individualizing Aspirin Therapy for Prevention of Cardiovascular Events

Article Abstract:

Physicians can use individual patient characteristics to determine which patients with cardiovascular disease should receive aspirin to prevent heart attack or stroke. Aspirin can substantially reduce the risk of heart attack and strokes caused by blood clots. However, because it prevents blood clotting, it increases the risk of hemorrhagic strokes. The benefits of aspirin will outweigh the risk of hemorrhagic stroke in patients with a high risk of heart attack. This may not be true in patients at low risk of a heart attack.

Author: Boissel, Jean-Pierre
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998
Health aspects, Editorial, Risk factors, Heart attack, Brain, Hemorrhage, Brain hemorrhage

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Prevention, Stroke (Disease), Stroke, Aspirin
Similar abstracts:
  • Abstracts: Empowering the carers of patients with dementia. Reducing paperwork in a medical assessment unit. Clinical protocols herald new era of nursing documentation
  • Abstracts: Achieving Magnet status. The nursing organization and the transformation of health care delivery for the 21st century
  • Abstracts: Pregnancy in patients with well-treated beta-thalassemia: outcome for mothers and newborn infants. Neurofibromatosis type 1 with pregnancy-associated renovascular hypertension and the syndrome of hemolysis, elevated liver enzymes, and low platelets
  • Abstracts: Antiretroviral therapy for HIV infection: promises and problems. HIV treatment strategies: planning for the long term
  • Abstracts: Alternative Medicine - Learning From the Past, Examining the Present, Advancing to the Future. A close look at therapeutic touch
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.